Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Octreotide for Palliation of Inoperable Bowel Obstruction: A Phase II Study

NCT00004895 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.

NCT NCT00004895
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00004895 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Octreotide for Palliation of Inoperable Bowel Obstruction: A Phase II Study
Lead sponsor
Northwestern University
Phase
Phase 2
Overall status
Completed
Start date
October 31, 1999
Completion date
October 31, 2002
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer, constipation, impaction, and bowel obstruction, extrahepatic bile duct cancer, gastric cancer, gastrointestinal stromal tumor, nausea and vomiting, ovarian cancer, pancreatic cancer, peritoneal cavity cancer, small intestine cancer